Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » CMS delays shift to new payment model for chronic kidney disease treatments

CMS delays shift to new payment model for chronic kidney disease treatments

By

CMS Centers for Medicare and Medicaid ServicesCMS will now wait until Jan. 1, 2022 to start its Kidney Care Choices model, meant to shift the way the U.S. treats chronic kidney disease.

The new payment model was supposed to start on Jan. 1 of this year, but health providers are still grappling with the COVID-19 pandemic.

The new model could have a major effect on dialysis treatment providers including DaVita Healthcare (NYSE:DVA) and Fresenius Medical Care (NYSE:FMS; ETR:FRE). Baxter (NYSE:BAX) meanwhile announced in 2019 that it was investing in technologies to support the effort.

The new model’s roots go back to former President Donald Trump’s 2019 executive order to emphasize transplants and home hemodialysis over in-clinic treatment. End-stage renal disease is one of the few conditions in the United States where there is already a single-payer system, thanks to a law signed by President Richard Nixon in 1972.

The Kidney Care Choices (KCC) model would provide strong financial incentives for healthcare providers’ accountable care organizations to better manage the care for Medicare beneficiaries with chronic kidney disease (CKD) stages 4 and 5 and end-stage renal disease — delaying the onset of dialysis and incentivizing kidney transplantation.

In case you missed it

RSS From Medical Design & Outsourcing

  • Qosina introduces RondelO stopcock manifolds
    NEWS RELEASE: Qosina Introduces RondelO™ Stopcock Manifolds Ronkonkoma, NY, USA, September 21, 2023—Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical industries, is pleased to introduce the RondelO™ stopcock manifold. The RondelO modernizes drug infusion protocols through an innovative, patented design. The RondelO is the world’s first medical stopcock manifold that… […]
  • Superior Sensor expands CPAP pressure sensor family
    NEWS RELEASE: Superior Sensor Technology Expands CPAP Pressure Sensor Family to Drive Better Patient Synchrony New CP Series Sensors Offer Faster System Response Time and New Safety Measures for PAP Devices, Providing a Higher Quality Patient Experience Los Gatos, CA,  September 27, 2023 – Superior Sensor Technology today announced two new CP Series pressure sensors for Positive Airway Pressure (PAP)… […]
  • CUI releases medical grade dc-dc converter with 2:1 input voltage and extended temperature range
    NEWS RELEASE: CUI Releases Medical Grade DC-DC Converter with 2:1 Input Voltage and Extended Temperature Range Tualatin, OR. [September 27, 2023] CUI Inc, a Bel group company, today announced the release of its PTP15 Series—a 15 W, 5 Pin DIP isolated dc-dc converter, specialized for medical instrumentation and home medical supplies. Offering 4000 Vac isolation… […]
  • Surface Solutions Group introduces sustainable, compliant GlideMed medical device coating
    NEWS RELEASE: Surface Solutions Group to Introduce Sustainable, Compliant GlideMed™ Medical Device Coating at MD&M Minneapolis CHICAGO, September 26, 2023 – ISO 13485 certified Surface Solutions Group, LLC (SSG), a leading provider of coating technologies for the medical device industry, today announced that it will be showcasing its GlideMed™ sustainable, compliant coating along with its… […]
  • RWE tips from Boston Scientific Peripheral Interventions CMO Dr. Michael Jaff
    Real-world evidence (RWE) is a transformational concept for medical device design and engineering, says Dr. Michael Jaff, the chief medical officer and VP of the Boston Scientific Peripheral Interventions business. “Every really great technological advancement in the vascular space has come from a physician’s recognition that they would like to be able to do something… […]
  • Resonant Link and Cirtec partner on implantable medical devices
    Resonant Link and Cirtec Medical have entered into a strategic partnership to serve developers of implantable medical devices. The two medtech suppliers said today that the partnership will combine Resonant Link’s next-generation wireless power technology with Cirtec Medical’s product design, development and manufacturing expertise to “offer medical device makers the best technology, fully integrated components,… […]
  • Johnson & Johnson MedTech plans manufacturing facility in Costa Rica
    Johnson & Johnson MedTech will build a 200,000-sf² manufacturing facility in Alajuela, Costa Rica, the medical device developer said today. It’s the largest investment J&J MedTech has ever made outside the U.S., according to Procomer, the agency that promotes Costa Rican exports. J&J MedTech — Johnson & Johnson’s medical device business, which by itself is… […]
  • The secret behind Intuitive’s surgical robotics success
    Intuitive Surgical has pioneered robotic surgery since the 1990s, continuously driving innovation and collaboration through data to advance patient care. Teamwork between surgeons and engineers has been a crucial factor behind Intuitive developing effective surgical platforms that solve real-world problems that surgeons face. Multibillion-dollar companies including Medtronic and Johnson & Johnson — and smaller up-and-comers… […]
  • 3D-printed ventricles made from fiber-infused gel ink mimic heartbeats
    Researchers have found a way to use fiber-infused ink to 3D-print a functional heart ventricle that mimics the beating of a human heart. The team included researchers from Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and the Wyss Institute for Biologically Inspired Engineering at Harvard University. They reported on their new… […]
  • Synchron’s plan to beat Neuralink in the neuroprosthetic BCI race
    Competing brain-computer interface (BCI) developers Synchron and Neuralink both announced big news this month as they move their dueling neuroimplant technologies forward. The device developers each have FDA investigational device exemption (IDE) for their experimental BCIs. They’ve also got billionaires backing their R&D and regulatory efforts, with Neuralink owned by Elon Musk and Synchron funded… […]
  • How LimFlow’s foot-saving system prevents amputations in patients with no other options
    LimFlow’s breakthrough system for treating chronic limb-threatening ischemia (CLTI) is the first of its kind approved by the FDA for this severe form of peripheral artery disease (PAD). For CLTI patients who have lost blood flow below their knee and have no other suitable endovascular or surgical treatment options available, the LimFlow System for Transcatheter… […]

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.

Copyright © 2023 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy